As of 2025-09-18, the Relative Valuation of Dyne Therapeutics Inc (DYN) is (38.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.15 USD, the upside of Dyne Therapeutics Inc based on Relative Valuation is -390.8%.
The range of the Relative Valuation is (37.09) - (39.30) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 13.6x | 13.2x |
| Forward P/E multiples | 12.8x - 13.5x | 13.2x |
| Fair Price | (37.09) - (39.30) | (38.24) |
| Upside | -382.1% - -398.8% | -390.8% |
| Date | P/E |
| 2025-09-11 | -4.51 |
| 2025-09-10 | -4.58 |
| 2025-09-09 | -4.57 |
| 2025-09-08 | -4.58 |
| 2025-09-05 | -4.90 |
| 2025-09-04 | -4.56 |
| 2025-09-03 | -4.64 |
| 2025-09-02 | -4.65 |
| 2025-08-29 | -4.65 |
| 2025-08-28 | -4.74 |
| 2025-08-27 | -4.70 |
| 2025-08-26 | -4.61 |
| 2025-08-25 | -4.48 |
| 2025-08-22 | -4.33 |
| 2025-08-21 | -4.21 |
| 2025-08-20 | -4.12 |
| 2025-08-19 | -4.22 |
| 2025-08-18 | -4.25 |
| 2025-08-15 | -4.27 |
| 2025-08-14 | -4.31 |
| 2025-08-13 | -4.22 |
| 2025-08-12 | -4.00 |
| 2025-08-11 | -3.87 |
| 2025-08-08 | -3.85 |
| 2025-08-07 | -3.86 |
| 2025-08-06 | -3.99 |
| 2025-08-05 | -3.61 |
| 2025-08-04 | -3.53 |
| 2025-08-01 | -3.46 |
| 2025-07-31 | -3.39 |
| 2025-07-30 | -3.41 |
| 2025-07-29 | -3.17 |
| 2025-07-28 | -3.21 |
| 2025-07-25 | -3.43 |
| 2025-07-24 | -3.18 |
| 2025-07-23 | -3.23 |
| 2025-07-22 | -3.17 |
| 2025-07-21 | -3.16 |
| 2025-07-18 | -3.11 |
| 2025-07-17 | -3.24 |
| 2025-07-16 | -3.21 |
| 2025-07-15 | -2.85 |
| 2025-07-14 | -3.07 |
| 2025-07-11 | -2.98 |
| 2025-07-10 | -3.03 |
| 2025-07-09 | -3.06 |
| 2025-07-08 | -2.89 |
| 2025-07-07 | -2.82 |
| 2025-07-03 | -3.02 |
| 2025-07-02 | -3.08 |